Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)

Douglas W. Blayney, Michael L. LeBlanc, Thomas Grogan, Ellen R. Gaynor, Robert A. Chapman, C. Harris Spiridonidis, Sarah A. Taylor, Scott I. Bearman, Thomas P. Miller, Richard I. Fisher

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Fingerprint

Dive into the research topics of 'Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349)'. Together they form a unique fingerprint.

Medicine & Life Sciences